Internal Medicine, Hematology & Oncology · Somerset, NJ
NPI
1063403509
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
75 Veronica Ave, Suite 201
Somerset, NJ, 08873
Phone (732) 246-4882
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
164,021 services
Medicare patients, 2024
791
Average age 76
Drug cost, 2024
$3.9M
1,137 prescriptions
Company payments, 2025
$391
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Craig Lampert was code J1439 (injection, ferric carboxymaltose, 1 mg), 63,750 times for 64 patients. In total Craig Lampert billed 164,021 services in 141 codes, and Medicare paid $2.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 63,750 | 64 | $0.88 | $56K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 12,180 | 20 | $2.29 | $28K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,800 | 16 | $44.50 | $347K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 4,200 | 11 | $35.72 | $150K |
| J1756 Injection, iron sucrose, 1 mg | Office | 3,000 | 11 | $0.14 | $429 |
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 16 | $20.77 | $47K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,930 | 32 | $0.09 | $170 |
| 36415 Venipuncture Blood Collection | Office | 1,023 | 391 | $8.64 | $8,840 |
| 85025 Blood Count | Office | 969 | 347 | $7.60 | $7,366 |
| 99214 Office E&M - Established | Office | 907 | 401 | $114.06 | $103K |
| 96372 Injection Administration | Office | 471 | 135 | $13.22 | $6,228 |
| 96367 Intravenous Infusion, Hydration | Office | 354 | 60 | $26.91 | $9,525 |
| 85027 Blood Count | Office | 308 | 136 | $6.34 | $1,953 |
| 99213 Office E&M - Established | Office | 303 | 192 | $80.35 | $24K |
| 99232 Hospital E&M - Subsequent | Facility | 283 | 100 | $71.80 | $20K |
By year: 2022 $2.0M for 159,771 services; 2023 $1.9M for 159,460 services; 2024 $2.3M for 164,021 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,023 | 391 | $8.64 | $8,840 |
| 85025 Blood Count | 969 | 347 | $7.60 | $7,366 |
| 85027 Blood Count | 308 | 136 | $6.34 | $1,953 |
Medicare prescription drug claims, 2024
In 2024, the drug Craig Lampert prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 131 prescriptions and refills. In total Craig Lampert wrote 1,137 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 131 | 131 | 21 | $231K |
| Anastrozole Generic | 111 | 324 | 36 | $2,877 |
| Aranesp Darbepoetin Alfa In Polysorbat | 69 | 75 | 20 | $202K |
| Eliquis Apixaban | 42 | 76 | 17 | $44K |
| Revlimid Lenalidomide | 37 | 37 | Under 11 | $649K |
| Sertraline Hcl Generic | 35 | 56 | Under 11 | $1,584 |
| Letrozole Generic | 34 | 94 | Under 11 | $656 |
| Hydroxyurea Generic | 34 | 44 | Under 11 | $583 |
| Warfarin Sodium Generic | 27 | 70 | Under 11 | $292 |
| Neulasta Pegfilgrastim | 25 | 25 | Under 11 | $159K |
| Oxycodone Hcl Generic | 24 | 26 | 12 | $402 |
| Lupron Depot Leuprolide Acetate | 24 | 38 | Under 11 | $74K |
| Ibrance Palbociclib | 23 | 23 | Under 11 | $346K |
| Calquence Acalabrutinib Maleate | 22 | 22 | Under 11 | $314K |
| Ondansetron Odt Ondansetron | 20 | 20 | Under 11 | $309 |
Brand drugs: 568 claims; generic drugs: 569 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig Lampert $391 ($391 in general payments such as food, travel and fees) from 17 companies. The largest payer was Caris MPI, Inc. with $40.22.
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 1 | $40.22 |
| GlaxoSmithKline, LLC. GSK | 2 | $39.45 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $34.89 |
| Aveo Pharmaceuticals, Inc. | 1 | $32.5 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $24.23 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.47 |
| Genmab U.S., Inc. GMAB | 1 | $23.05 |
| Deciphera Pharmaceuticals Inc. | 1 | $22.69 |
| Astellas Pharma US Inc 4503.T | 1 | $19.52 |
| Geron Corporation GERN | 1 | $17.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.